Time-activity curves (TAC) for the bone marrow self-absorbed dose as determined via the blood method and for both Lu-177-Octreotate (a) and Lu-177-PSMA-617 therapy (b) (according to Eqs. (3.1) and (3.3)); the patient-specific TACs are shown in black, while the median is presented in red